Table of Contents
Key Takeaway
Tea drinkers show a statistical association with lower fatty liver risk, but the overall result of a 15-study meta-analysis was not statistically significant — and a genetic study found no causal link at all. The relationship between tea and fatty liver disease is more nuanced than any headline can capture.
Evidence Level: Moderate — Based on a systematic review and meta-analysis of 15 observational studies (N = 1,398,936), with contradicting Mendelian randomization evidence.
Does your daily cup of green tea actually protect your liver, or do tea drinkers just happen to have healthier habits overall?
That question sits at the center of a March 2026 meta-analysis published in Health Science Reports by Verma, Sah, and Mehta. They pooled data from 15 observational studies covering nearly 1.4 million participants to test whether tea consumption reduces the risk of non-alcoholic fatty liver disease (NAFLD). The headline number, a 14.5% risk reduction, made waves. But the full picture is messier and more interesting than “tea prevents fatty liver disease.”
Does Tea Protect Against Fatty Liver Disease?
Start with what looks promising. The meta-analysis found that when researchers tracked people over time using cohort studies, tea drinkers had a statistically significant 14.5% lower risk of developing NAFLD (HR 0.855, 95% CI: 0.815–0.896). A cross-sectional subgroup showed even stronger results: 37.2% lower odds (OR 0.628, 95% CI: 0.420–0.939).
The biological story is plausible too. Green tea’s primary catechin, EGCG, activates liver-protective pathways in lab settings. A 2021 review in Antioxidants documented how EGCG reduces hepatic fat accumulation through AMPK activation, suppresses inflammation via NF-kappaB, and boosts antioxidant defenses through NRF2 enhancement. In cell and animal models, these mechanisms are well-established.
And NAFLD is no minor concern. It affects roughly 30% of the global population, with prevalence rising from 25% in 1990-2006 to 38% by 2016-2019, according to Teng et al. (2023) in Clinical and Molecular Hepatology. No FDA-approved drug exists specifically for NAFLD. A dietary intervention that could move the needle, even modestly, would matter.
The Case Against
The story turns here. The overall pooled odds ratio of the meta-analysis was 0.782, but the 95% confidence interval crossed 1.0 (0.549–1.113). In statistical terms, the overall result was not significant. The protective findings came only from subgroup analyses, not the primary outcome.
Heterogeneity was high. The I-squared value hit 84%, meaning the 15 studies disagreed with each other substantially. They used different study designs, different definitions of tea consumption, different NAFLD diagnostic methods (ultrasound vs. fatty liver index vs. biopsy), and covered different populations across different dietary cultures.
Then there’s the genetics problem. A 2024 Mendelian randomization study by Lu et al. in Metabolism Open used genetic variants from 447,485 UK Biobank participants to test whether genetically predicted tea intake affects NAFLD risk. The result: no causal relationship (OR 1.48, 95% CI: 0.64–3.43, p = 0.364). Mendelian randomization is specifically designed to cut through the confounding that plagues observational data. When it returns a null result while observational studies show a benefit, the most likely explanation is confounding — not causation.
And confounding is everywhere here. Tea drinkers tend to exercise more, eat better, and smoke less. That’s the healthy-user bias, and many of the 15 included studies couldn’t fully adjust for it.
The Sugar Problem
One finding deserves its own section. A 2025 longitudinal study by Qaisar et al. in BMC Nutrition (n = 2,537) found that heavy tea drinkers (more than 2.88 cups per day) actually had 27% lower likelihood of liver fat improvement. When the researchers controlled for sugar intake, the association disappeared entirely.
This matters because most observational studies in the meta-analysis did not distinguish between sweetened and unsweetened tea. If you’re adding two spoonfuls of sugar to every cup, or drinking bubble tea loaded with syrup, the potential benefit from catechins may be canceled out (or reversed) by the metabolic cost of excess sugar. Sugar-sweetened beverages are independently linked to fatty liver disease, and the liver is where fructose metabolism primarily occurs.
The Supplement Paradox
One irony worth noting: concentrated green tea supplements, the ones marketed for liver health, can actually damage the liver. The European Food Safety Authority flagged EGCG doses above 800 mg/day in supplement form as a hepatotoxicity risk. Case reports in the LiverTox database document liver injury at doses as low as 140 mg/day in susceptible individuals. A standard cup of brewed green tea contains 50–100 mg of EGCG. Supplements can pack 400–800 mg per capsule.
The dose makes the poison. Brewed tea is safe. Mega-dose extracts are not.
What to Actually Do
- Drink tea unsweetened. The potential benefit, if it exists, likely applies only to tea without added sugar. Any ultra-processed additions may negate the effect.
- Stick with brewed tea, not supplements. Green tea extract supplements carry real hepatotoxicity risk at high doses. Two to three cups of brewed green tea daily falls well within safe limits.
- Don’t treat tea as medicine. The overall meta-analysis result was not statistically significant. Tea is a reasonable part of a liver-friendly diet, not a treatment for fatty liver disease.
- Address the bigger levers first. Weight management, physical activity, reduced alcohol, and a Mediterranean-style diet have stronger evidence for NAFLD prevention than any single beverage.
If You Do One Thing
Swap one sweetened drink per day for unsweetened green tea. Not because the science proves tea cures fatty liver. It doesn’t. But because removing the sugar helps your liver, and the tea gives you something pleasant to drink instead. The catechins may or may not add a modest benefit on top. The sugar reduction definitely does.
Related Reading
- Which Nutrients Actually Prevent Chronic Disease? A 208,312-Person Study
- 7 Foods That Help You Sleep Better, Backed by Research
- Ultra-Processed Food Health Risks: 2025 Lancet Findings
- How Sleep Shapes Your Gut Microbiome — and Why It Matters
- Is Bubble Tea Bad for You? What New Research Found
Sources
- Verma A et al. (2026) — Systematic review and meta-analysis of tea consumption and NAFLD, Health Science Reports — Primary source; 15 studies, N = 1,398,936
- Teng ML et al. (2023) — Global NAFLD prevalence meta-analysis, Clinical and Molecular Hepatology — NAFLD affects 30% of global population
- Mahmoodi M et al. (2021) — EGCG mechanisms in NAFLD, Antioxidants — Catechin pathways review
- Lu C et al. (2024) — Mendelian randomization of tea and NAFLD, Metabolism Open — No causal link found (OR 1.48, p = 0.364)
- Qaisar et al. (2025) — Tea consumption and hepatic steatosis, BMC Nutrition — Sugar confound eliminates association
- EFSA Scientific Opinion (2018) — Safety of green tea catechins, EFSA Journal — EGCG >800 mg/day hepatotoxicity risk
- LiverTox — Green Tea entry, NCBI Bookshelf — Case reports of supplement-induced liver injury